Gleam

Gleam's product page describes a browser-based data-entry assistant that learns your EDC rather than integrating with it. That distinction is the whole pitch, and it is a meaningful one for research sites. Integration projects between eSource and EDC systems normally require sponsor cooperation, vendor involvement, and IT time; Gleam instead learns CRF data fields directly from the EDC pages in your browser, then fetches matching values from eSource and fills the form. The vendor's two learning modes make the tradeoff explicit: Quick learn examines and learns the structure of each CRF page, and you can queue multiple CRFs so it learns them in parallel while you work on other tasks. Deep learn has Gleam visibly click through interactive form elements to develop a precise understanding of a CRF, which the vendor says unlocks Fast Fill on subsequent visits. It also tracks protocol amendments so it knows what to relearn automatically — a detail that matters in trials where the CRF changes mid-study.\n\nThe Fetch step works with browser-based eSource and presents anything uncertain for review and approval rather than committing it silently. Gleam will also flag gaps in your source build, such as missing data fields; one quoted site director said it helped them spot gaps in their own source design. The Fill step pre-fills logs, so a visit that generates dozens of concomitant medication entries can be confirmed row by row instead of typed from scratch. Trace gives you View Source to jump back to the exact eSource location and View Destination to scroll to the relevant CRF field, plus hover details on CRF fields and keyword search over visit data.\n\nStrengths: fast site-level adoption, per-field source traceability, QC-oriented review of low-confidence data, and error detection during entry. Weaknesses and gaps: paper and PDF source support is still "coming soon"; the product is a Chrome browser extension, so teams wanting offline or desktop-only workflows are out of scope; and there is no centralized multi-site oversight for sponsors or CROs. Gleam contracts directly with sites, which is what makes the no-sponsor-approval adoption possible, but it also means Gleam is not the system of record for a trial. Treat it as an assistant that sits on top of the EDC you already use, not a replacement for it.